company background image
ABSI

Absci NasdaqGS:ABSI Stock Report

Last Price

US$3.35

Market Cap

US$309.5m

7D

2.8%

1Y

-53.5%

Updated

04 Feb, 2023

Data

Company Financials +

ABSI Stock Overview

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States.

ABSI fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

My Notes

New

Notes are coming soon

Absci Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Absci
Historical stock prices
Current Share PriceUS$3.35
52 Week HighUS$9.68
52 Week LowUS$1.94
Beta0
1 Month Change40.76%
3 Month Change15.12%
1 Year Change-53.47%
3 Year Changen/a
5 Year Changen/a
Change since IPO-84.48%

Recent News & Updates

Recent updates

Absci GAAP EPS of -$0.32 misses by $0.01, revenue of $1M misses by $0.68M

Aug 11

Absci teams up to help develop antibody drugs for cancer

Jul 07

Merck And Absci: AI-Driven Drug Development Deal Has Promise, But May Take Years To Pay Out

Jan 10

IPO Day With Absci CEO Sean McClain - The Google Of Synthetic Biology (Video)

Jul 22

Shareholder Returns

ABSIUS BiotechsUS Market
7D2.8%-0.8%1.7%
1Y-53.5%4.4%-9.6%

Return vs Industry: ABSI underperformed the US Biotechs industry which returned 4.5% over the past year.

Return vs Market: ABSI underperformed the US Market which returned -8.5% over the past year.

Price Volatility

Is ABSI's price volatile compared to industry and market?
ABSI volatility
ABSI Average Weekly Movement15.9%
Biotechs Industry Average Movement12.1%
Market Average Movement6.7%
10% most volatile stocks in US Market17.5%
10% least volatile stocks in US Market2.8%

Stable Share Price: ABSI is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 16% a week.

Volatility Over Time: ABSI's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2011212Sean McClainhttps://www.absci.com

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Absci Corporation Fundamentals Summary

How do Absci's earnings and revenue compare to its market cap?
ABSI fundamental statistics
Market CapUS$309.52m
Earnings (TTM)-US$110.60m
Revenue (TTM)US$5.64m

54.9x

P/S Ratio

-2.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ABSI income statement (TTM)
RevenueUS$5.64m
Cost of RevenueUS$63.36m
Gross Profit-US$57.72m
Other ExpensesUS$52.88m
Earnings-US$110.60m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.20
Gross Margin-1,022.99%
Net Profit Margin-1,960.28%
Debt/Equity Ratio3.0%

How did ABSI perform over the long term?

See historical performance and comparison